JPMorgan Chase & Co. - Net Worth and Insider Trading
JPMorgan Chase & Co. Net Worth
The estimated net worth of JPMorgan Chase & Co. is at least $11 Million dollars as of 2025-05-28. JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Shanghai Bio-heart Biological Technology Co Ltd and owns about 4,261,723 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) stock worth over $11 Million. Details can be seen in JPMorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that JPMorgan Chase & Co. has not made any transactions after 2023-01-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of JPMorgan Chase & Co.
JPMorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, JPMorgan Chase & Co. owns 1 companies in total, including Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) .
Click here to see the complete history of JPMorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of JPMorgan Chase & Co.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02185 | Shanghai Bio-heart Biological Technology Co Ltd | 2023-01-12 | 2201 Interest of corporation controlled by you |
JPMorgan Chase & Co. Latest Holdings Summary
JPMorgan Chase & Co. currently owns a total of 1 stock. JPMorgan Chase & Co. owns 4,261,723 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) as of January 12, 2023, with a value of $11 Million.
Latest Holdings of JPMorgan Chase & Co.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02185 | Shanghai Bio-heart Biological Technology Co Ltd | 2023-01-12 | 4,261,723 | 2.56 | 10,910,011 |
Holding Weightings of JPMorgan Chase & Co.
JPMorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, JPMorgan Chase & Co. has made a total of 16 transactions in Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) over the past 5 years, including 4 buys and 4 sells. The most-recent trade in Shanghai Bio-heart Biological Technology Co Ltd is the sale of 621,200 shares on January 12, 2023, which brought JPMorgan Chase & Co. around $4 Million.
Insider Trading History of JPMorgan Chase & Co.
- 1
JPMorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of JPMorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by JPMorgan Chase & Co. is -36.55%. GuruFocus also compares JPMorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by JPMorgan Chase & Co. within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how JPMorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of JPMorgan Chase & Co.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.05 | | | | | |
| Relative Return to S&P 500(%) | -13.98 | | | | | |
JPMorgan Chase & Co. Ownership Network
Ownership Network List of JPMorgan Chase & Co.
Ownership Network Relation of JPMorgan Chase & Co.
JPMorgan Chase & Co. Owned Company Details
What does Shanghai Bio-heart Biological Technology Co Ltd do?
Who are the key executives at Shanghai Bio-heart Biological Technology Co Ltd?
JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Shanghai Bio-heart Biological Technology Co Ltd. Other key executives at Shanghai Bio-heart Biological Technology Co Ltd include 2201 Interest of corporation controlled by you TPG Operating Group II, L.P. , 2201 Interest of corporation controlled by you Chen Hao , and 2201 Interest of corporation controlled by you Zhu Linan .
Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) Insider Trades Summary
Over the past 18 months, JPMorgan Chase & Co. made no insider transaction in Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185). Other recent insider transactions involving Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) include a net sale of 0 shares made by TPG Operating Group II, L.P. ,
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Bio-heart Biological Technology Co Ltd Insider Transactions
JPMorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for JPMorgan Chase & Co.. Currently GuruFocus does not have mailing address information for JPMorgan Chase & Co..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
